|
Apr 28
|
2 Beaten-Down Dividend Stocks to Buy and Hold Forever
|
|
Apr 26
|
ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside?
|
|
Apr 23
|
It’s Draft Day: Damar Hamlin Helps Build the Abbott HeartMates Team
|
|
Apr 20
|
We Think Some Shareholders May Hesitate To Increase Abbott Laboratories' (NYSE:ABT) CEO Compensation
|
|
Apr 19
|
Should You Expect Accelerating Earnings Growth for Abbott Laboratories (ABT)?
|
|
Apr 19
|
Results: Abbott Laboratories Beat Earnings Expectations And Analysts Now Have New Forecasts
|
|
Apr 18
|
Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript
|
|
Apr 18
|
Abbott Laboratories First Quarter 2024 Earnings: EPS Beats Expectations
|
|
Apr 18
|
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations ...
|
|
Apr 18
|
Q1 2024 Abbott Laboratories Earnings Call
|
|
Apr 17
|
Abbott Undercuts Its 200-Day Line And A Flat Base Despite Its 'Solid' Quarterly Report
|
|
Apr 17
|
U.S. Stocks Slide On Tech Weakness
|
|
Apr 17
|
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript
|
|
Apr 17
|
Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance
|
|
Apr 17
|
Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
|
|
Apr 17
|
Abbott Labs posts Q1 earnings beat
|
|
Apr 17
|
Abbott Labs Stock Is Slipping After Earnings Beat. Here’s Why.
|
|
Apr 17
|
Abbott (ABT) Reports Q1 Earnings: What Key Metrics Have to Say
|
|
Apr 17
|
Abbott Laboratories (ABT) Q1 Earnings: Surpasses EPS Estimates and Raises Full-Year Guidance
|
|
Apr 17
|
Abbott (ABT) Tops Q1 Earnings and Revenue Estimates
|